Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Beatrice Astruc"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 11, Pp 2674-2677 (2017)
An inactivated split-virion trivalent influenza vaccine (IIV3; Vaxigrip®, Sanofi Pasteur) has been available globally since 1968. Here, we describe the results of an open-label, post-licensure trial (EudraCT no. 2014-005078-12) to confirm the immuno
Externí odkaz:
https://doaj.org/article/6cf57ac016944973ad180080db37e806
Autor:
Ingo Meyer, Sanie S. S. Sesay, Corinne Vandermeulen, Regine Rouzier, Jerzy Brzostek, Pierre Van Damme, Beatrice Astruc, Edyta Kowalska, Stephanie Pepin, Camille Salamand, Nicole Toursarkissian, Yves Donazzolo, Henryk Szymański, Geert Leroux-Roels
Publikováno v:
Human Vaccines & Immunotherapeutics
Human vaccines & immunotherapeutics
Human vaccines & immunotherapeutics
Here, we report a randomized multicenter phase III trial assessing the lot-to-lot consistency of the 2014-2015 Northern Hemisphere quadrivalent split-virion inactivated influenza vaccine (IIV4; Sanofi Pasteur) and comparing its immunogenicity and saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f12d14fd8c93e208886e0939d0d49ac
https://doi.org/10.1080/21645515.2017.1384106
https://doi.org/10.1080/21645515.2017.1384106
Publikováno v:
Human Vaccines & Immunotherapeutics
An inactivated split-virion trivalent influenza vaccine (IIV3; Vaxigrip®, Sanofi Pasteur) has been available globally since 1968. Here, we describe the results of an open-label, post-licensure trial (EudraCT no. 2014-005078-12) to confirm the immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0286dcccd89993fefaf4062a271cc3
https://doi.org/10.1080/21645515.2017.1363944
https://doi.org/10.1080/21645515.2017.1363944
Autor:
Soren Brage, Elana Henning, John P. Mayer, Jerry R. Greenfield, Gregory S Cameron, Jeffrey W Miller, Teik Choon See, Stephen O'Rahilly, I. Sadaf Farooqi, Julia M. Keogh, David J. Lomas, Beatrice Astruc, Julie Satterwhite
Publikováno v:
New England Journal of Medicine. 360:44-52
Weight gain and weight loss are associated with changes in blood pressure through unknown mechanisms. Central melanocortinergic signaling is implicated in the control of energy balance and blood pressure in rodents, but there is no information regard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f1340a42cdcbb1f2b44d948fc59b1e
https://doi.org/10.1056/nejmoa0803085
https://doi.org/10.1056/nejmoa0803085
Autor:
Sanie Sesay, Jerzy Brzostek, Ingo Meyer, Yves Donazzolo, Geert Leroux-Roels, Régine Rouzier, Béatrice Astruc, Henryk Szymanski, Nicole Toursarkissian, Corinne Vandermeulen, Edyta Kowalska, Pierre Van Damme, Camille Salamand, Stephanie Pepin
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 3, Pp 596-608 (2018)
Here, we report a randomized multicenter phase III trial assessing the lot-to-lot consistency of the 2014–2015 Northern Hemisphere quadrivalent split-virion inactivated influenza vaccine (IIV4; Sanofi Pasteur) and comparing its immunogenicity and s
Externí odkaz:
https://doaj.org/article/35ff4bf25525427ab78bf62f189aa6ef
Autor:
Matthew W McClure, Elina Berliba, Tengiz Tsertsvadze, Adrian Streinu-Cercel, Leen Vijgen, Béatrice Astruc, Alain Patat, Christopher Westland, Sushmita Chanda, Qingling Zhang, Thomas N Kakuda, Jennifer Vuong, Nick Khorlin, Leonid Beigelman, Lawrence M Blatt, John Fry
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0204974 (2018)
BACKGROUND:The nucleotide analog AL-335 is a pangenotypic hepatitis C virus (HCV) nonstructural protein (NS)5B inhibitor being evaluated as treatment for chronic HCV infection. METHODS:This three-part randomized, double-blind study evaluated the safe
Externí odkaz:
https://doaj.org/article/734ab2d56f1a434cbd65736ecb72aa86